| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
5 companies
Vivo Capital Viii, LLC serves as a 10% Owner at VYNE and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 14 buys and 49 sells. Those positions are worth an estimated $108.5M at current prices.
Historically, Vivo Capital Viii, LLC's trades have earned a middling insider score of 57/100 across 4 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +38.4%.
The biggest single holding is VYNE (~$74.5M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 294,118 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2023 | BOLT Bolt Biotherapeutics, Inc. | 10% Owner | Sell | 3,400 | $0.90 | $3,060.00 | -0.1% | +32.9% | -34.1% | |
| Nov 20, 2023 | BOLT Bolt Biotherapeutics, Inc. | 10% Owner | Sell | 86,054 | $0.93 | $79,933.22 | -1.2% | +25.7% | -38.7% | |
| Feb 9, 2021 | TERN Terns Pharmaceuticals, Inc. | 10% Owner | Buy | 475,000 | $17.00 | $8,075,000.00 | +21.6% | - | - | |
| Feb 9, 2021 | BOLT Bolt Biotherapeutics, Inc. | 10% Owner | Sell | 226 | $20.00 | $4,520.00 | - | - | - | |
| Feb 9, 2021 | BOLT Bolt Biotherapeutics, Inc. | 10% Owner | Buy | 350,000 | $20.00 | $7,000,000.00 | +16.9% | - | - | |
| Oct 20, 2020 | ALGS Aligos Therapeutics, Inc. | 10% Owner | Buy | 550,000 | $15.00 | $8,250,000.00 | +18.4% | - | - | |
| Apr 17, 2020 | CRNX Crinetics Pharmaceuticals, Inc. | 10% Owner | Sell | 330,598 | $15.45 | $5,106,752.20 | -4.2% | - | - | |
| Apr 7, 2020 | CRNX Crinetics Pharmaceuticals, Inc. | 10% Owner | Sell | 306,115 | $13.81 | $4,226,833.00 | -5.2% | - | - | |
| Mar 9, 2020 | CRNX Crinetics Pharmaceuticals, Inc. | 10% Owner | Sell | 528 | $19.50 | $10,296.00 | - | - | - | |
| Feb 10, 2020 | CRNX Crinetics Pharmaceuticals, Inc. | 10% Owner | Sell | 13,460 | $21.66 | $291,587.00 | -0.2% | - | - |